Artwork

ConteĂșdo fornecido por Jon Chee. Todo o conteĂșdo do podcast, incluindo episĂłdios, grĂĄficos e descriçÔes de podcast, Ă© carregado e fornecido diretamente por Jon Chee ou por seu parceiro de plataforma de podcast. Se vocĂȘ acredita que alguĂ©m estĂĄ usando seu trabalho protegido por direitos autorais sem sua permissĂŁo, siga o processo descrito aqui https://pt.player.fm/legal.
Player FM - Aplicativo de podcast
Fique off-line com o app Player FM !

🧬 David Li - Meliora Therapeutics - Part 2 | From Finance to Biotech Entrepreneurship | Building Solid Teams & Navigating Market Dynamics | Lessons in Early-Stage Startups

25:01
 
Compartilhar
 

Manage episode 426981165 series 3461709
ConteĂșdo fornecido por Jon Chee. Todo o conteĂșdo do podcast, incluindo episĂłdios, grĂĄficos e descriçÔes de podcast, Ă© carregado e fornecido diretamente por Jon Chee ou por seu parceiro de plataforma de podcast. Se vocĂȘ acredita que alguĂ©m estĂĄ usando seu trabalho protegido por direitos autorais sem sua permissĂŁo, siga o processo descrito aqui https://pt.player.fm/legal.
As a podcast listener, you can redeem exclusive discounts with a growing list of biotech vendors and get $500 off your first equipment lease by using promo code “TBSP” on https://www.excedr.com/rewards.

Part 2 of 4.

My guest for this week’s episode is David Li, CEO and co-founder of Meliora Therapeutics. Meliora's goal is to develop life-saving cancer therapies using cutting-edge science and machine learning. The company derives a comprehensive picture of how drugs interact with cancer biology by combining biofunctional readouts from numerous modalities using advanced machine learning and other computational techniques.

Before Meliora, David served as Chief Business Officer at Everest Detection, an early detection liquid biopsy startup, and was head of commercial operations at Benchling, a life sciences software platform company which has achieved a $6 billion valuation and has attracted over $500 million in funding.

David began his career in Goldman Sachs Healthcare Investment Banking Group and KKR's Private Equity Group, where he advised and invested in transactions worth over $10 billion in enterprise value. His multifaceted experiences in the financial and life science sectors give him a wide range of experiences that founders can learn from.

Join us this week and hear about:

  • David’s pivot from finance roles at Goldman Sachs and KKR to early-stage entrepreneurship in the Life Sciences
  • The challenges of moving from private equity to startups
  • Aligning personal values with career choices, building solid teams, and the role of luck in success.
  • His time at Benchling as Head of Commercial Operations and at Everest Detection as the Chief Business Officer

Please enjoy my conversation with David Li.

Timestamps:
00:28 Intro
01:56 Working in Finance at Goldman Sachs and KKR, rethinking how to make an impact
04:59 Switching to early-stage entrepreneurship, prioritizing team strength and market dynamics
06:25 Experience at Benchling, data software issues & digitization in the life sciences
11:09 The role of luck in success, figuring out what you can and can’t control
14:02 Challenges and lessons working in startups, maintaining internal conviction
17:43 Contemplating a new role after Benchling, joining Everest Detection
20:25 The different skills David learned while building a team, getting wins early on
23:56 Outro

Find Our Guest, David Li, at these links:

Find Our Host, Jon Chee, at these links:

Social & Website

Enriched Notes:

Topics Mentioned:

People Mentioned:
The Biotech Startups Podcast is handcrafted by our friends over at: fame.so
  continue reading

76 episĂłdios

Artwork
iconCompartilhar
 
Manage episode 426981165 series 3461709
ConteĂșdo fornecido por Jon Chee. Todo o conteĂșdo do podcast, incluindo episĂłdios, grĂĄficos e descriçÔes de podcast, Ă© carregado e fornecido diretamente por Jon Chee ou por seu parceiro de plataforma de podcast. Se vocĂȘ acredita que alguĂ©m estĂĄ usando seu trabalho protegido por direitos autorais sem sua permissĂŁo, siga o processo descrito aqui https://pt.player.fm/legal.
As a podcast listener, you can redeem exclusive discounts with a growing list of biotech vendors and get $500 off your first equipment lease by using promo code “TBSP” on https://www.excedr.com/rewards.

Part 2 of 4.

My guest for this week’s episode is David Li, CEO and co-founder of Meliora Therapeutics. Meliora's goal is to develop life-saving cancer therapies using cutting-edge science and machine learning. The company derives a comprehensive picture of how drugs interact with cancer biology by combining biofunctional readouts from numerous modalities using advanced machine learning and other computational techniques.

Before Meliora, David served as Chief Business Officer at Everest Detection, an early detection liquid biopsy startup, and was head of commercial operations at Benchling, a life sciences software platform company which has achieved a $6 billion valuation and has attracted over $500 million in funding.

David began his career in Goldman Sachs Healthcare Investment Banking Group and KKR's Private Equity Group, where he advised and invested in transactions worth over $10 billion in enterprise value. His multifaceted experiences in the financial and life science sectors give him a wide range of experiences that founders can learn from.

Join us this week and hear about:

  • David’s pivot from finance roles at Goldman Sachs and KKR to early-stage entrepreneurship in the Life Sciences
  • The challenges of moving from private equity to startups
  • Aligning personal values with career choices, building solid teams, and the role of luck in success.
  • His time at Benchling as Head of Commercial Operations and at Everest Detection as the Chief Business Officer

Please enjoy my conversation with David Li.

Timestamps:
00:28 Intro
01:56 Working in Finance at Goldman Sachs and KKR, rethinking how to make an impact
04:59 Switching to early-stage entrepreneurship, prioritizing team strength and market dynamics
06:25 Experience at Benchling, data software issues & digitization in the life sciences
11:09 The role of luck in success, figuring out what you can and can’t control
14:02 Challenges and lessons working in startups, maintaining internal conviction
17:43 Contemplating a new role after Benchling, joining Everest Detection
20:25 The different skills David learned while building a team, getting wins early on
23:56 Outro

Find Our Guest, David Li, at these links:

Find Our Host, Jon Chee, at these links:

Social & Website

Enriched Notes:

Topics Mentioned:

People Mentioned:
The Biotech Startups Podcast is handcrafted by our friends over at: fame.so
  continue reading

76 episĂłdios

Alle episoder

×
 
Loading …

Bem vindo ao Player FM!

O Player FM procura na web por podcasts de alta qualidade para vocĂȘ curtir agora mesmo. É o melhor app de podcast e funciona no Android, iPhone e web. Inscreva-se para sincronizar as assinaturas entre os dispositivos.

 

Guia rĂĄpido de referĂȘncias